EGFR and lung carcinoma: In this context, we analyzed the expression data of various lung-cancer cell lines that are sensitive or resistant (PC9 and Hcc827, respectively) to EGFR TKi (Figure 6A—data from Song et al.)[117], (Figure 6B—data from Ware et al.)[118].